IMUNON, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 USD | 0.00% |
|
+1.45% | +105.88% |
| May. 13 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
| May. 08 | IMUNON, Inc. Appoints Stacy R. Lindborg as Chief Executive Officer, Effective May 13, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMUNON, INC. | Bio Therapeutic Drugs | 0.00% | +1.45% | +105.88% | +6.06% | -95.64% | 13.16M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMNN Stock
- Charts Imunon, Inc.
- Comparison Chart
